Labcorp Plasma Focus Liquid Biopsy Test Launches
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Cancer |
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Molecular Diagnostics |
GT Molecular, Inc. is entering the cancer molecular assay market with multi-target PCR kits featuring quality control metrics.
Read MorePosted by Melanie Hamilton-Basich | May 30, 2023 | Lung Cancer |
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read MorePosted by Chris Wolski | May 29, 2023 | Cancer |
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Hematology & Serology, Lung Cancer |
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read More